Meta-analysis shows no significant associations for children, adolescents, or adults, for female patients, or for those with preexisting CVD
Risk for preterm birth, small size for gestational age, low birth weight lower for those receiving buprenorphine versus methadone
Moderately less decline seen in cognition and function at 18 months with lecanemab versus placebo
No significantly increased risk seen for ADHD or ASD with exposure to benzodiazepines during first, second, third trimester
Findings even stronger for young people with a recent opioid prescription
Red flags include pharmacies that do not require a doctor's prescription or have a licensed pharmacist to answer questions
77 percent of the cases of pediatric exposure reported to U.S. poison control centers were for unintentional exposure
Colorado voters approved a measure to make the medical use of 'magic mushrooms' legal, paving the way for its use in treating several mental health disorders
The two most common, valproic acid and gabapentin, being used in clinically distinct ways
Substantial number of Veterans Health Administration patients received buprenorphine from phone-only telehealth